380 studies found for:    (human papillomavirus OR hpv) AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Completed Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
Conditions: Neoplasms, Uterine Cervix;   Cervical Cancer
Interventions: Procedure: Cervical sampling;   Other: Data collection
22 Completed Evaluation of Immunogenicity Levels in Women With HPV Vaccine in Mexico
Conditions: Human Papillomavirus 16;   Human Papillomavirus 18;   Vaccines
Interventions: Biological: Bivalent Vaccines;   Biological: Tetravalent Vaccine
23 Enrolling by invitation The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling
Condition: HIV Infection
Intervention: Other: Self-Collected HPV Test
24 Completed Knowledge and Attitude About HPV Vaccines
Conditions: Knowledge;   Attitude;   Behavior
Intervention: Behavioral: educative  folder
25 Completed
Has Results
Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
Conditions: HIV Infections;   Sexually Transmitted Diseases
Intervention: Biological: Quadrivalent HPV vaccine
26 Active, not recruiting A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Condition: Human Papillomavirus Infection
Intervention: Biological: V503 (9-valent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) vaccine)
27 Unknown  Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.
Conditions: 1- Women;   2- HIV Infection;   3- Followed in West Indies and French Guiana for His Infection;   4- Acceptance of the Use of Nadis® Medical Files
Intervention: Other: Biological Sample collection
28 Completed Impact of an HPV Vaccine in HIV-Infected Young Women
Condition: HIV Infection
Intervention: Biological: HPV vaccine for strains -6, -11, -16, and -18
29 Completed Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
Condition: Cervical Cancer
Intervention: Drug: Licensed quadrivalent HPV vaccine, Gardasil
30 Recruiting Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Condition: Infections, Papillomavirus
Interventions: Biological: GSK Biologicals' HPV vaccine 580299;   Biological: Merck's Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine (Gardasil)
31 Completed
Has Results
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
Conditions: Human Papillomavirus (HPV) Infection;   Papillomavirus Vaccines;   Cervical Neoplasia
Interventions: Biological: Placebo;   Biological: Cervarix TM
32 Completed
Has Results
Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects
Condition: HPV-16/18 Infections.
Interventions: Biological: CervarixTM;   Other: Control
33 Active, not recruiting
Has Results
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
Condition: Infections, Papillomavirus
Interventions: Procedure: Blood sampling;   Procedure: Cervico-vaginal secretion (CVS) samples
34 Completed
Has Results
A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females
Conditions: Human Papillomavirus (HPV) Infection;   Papillomavirus Vaccines
Intervention: Biological: GSK580299 (Cervarix™ , HPV -16/18 L1 VLP AS04 vaccine)
35 Completed
Has Results
V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)(COMPLETED)
Condition: HPV Infections
Interventions: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (V501);   Biological: Comparator: Placebo (unspecified)
36 Completed
Has Results
Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)
Condition: Papillomavirus Infections
Intervention: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine
37 Completed A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil
Conditions: HIV;   HIV Infections
38 Completed
Has Results
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Uterine Cervical Dysplasia
Intervention: Biological: Human Papillomavirus Vaccine
39 Recruiting Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine in Healthy Female Children
Condition: Infections, Papillomavirus
Interventions: Biological: Cervarix;   Biological: MMR;   Biological: DTPa
40 Completed
Has Results
Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women
Conditions: Cervical Cancer;   Papillomavirus Infection
Interventions: Biological: Placebo;   Biological: HPV-16/18 VLP/AS04 Vaccine (Cervarix TM)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years